These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. "On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment. Frattola L; Albizzati MG; Bassi S; Ferrarese C; Trabucchi M Acta Neurol Scand; 1982 Aug; 66(2):227-36. PubMed ID: 7136487 [TBL] [Abstract][Full Text] [Related]
47. Lisuride and pergolide in Parkinson's disease. Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769 [No Abstract] [Full Text] [Related]
48. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease. Laihinen A; Rinne UK; Suchy I Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646 [TBL] [Abstract][Full Text] [Related]
50. Intravenous lisuride infusion for Parkinson's disease. Obeso JA; Martinez-Lage JM; Luquin MR; Bolio N Ann Neurol; 1983 Aug; 14(2):252. PubMed ID: 6625541 [No Abstract] [Full Text] [Related]
51. Pergolide and lisuride for Parkinson's disease. Lieberman AN; Leibowitz M; Neophytides A; Kupersmith M; Mehl S; Kleinberg D; Serby M; Goldstein M Lancet; 1979 Nov; 2(8152):1129-30. PubMed ID: 91856 [No Abstract] [Full Text] [Related]
52. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study. LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825 [TBL] [Abstract][Full Text] [Related]
53. Transdihydrolisuride in parkinsonism. Critchley P; Parkes D Clin Neuropharmacol; 1987; 10(1):57-64. PubMed ID: 3815388 [TBL] [Abstract][Full Text] [Related]
54. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease. Lestingi L; Bonifati V; Stocchi F; Antonozzi I; Meco G Eur Neurol; 1992; 32(2):65-9. PubMed ID: 1563463 [TBL] [Abstract][Full Text] [Related]
55. The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. Lieberman AN; Leibowitz M; Gopinathan G; Walker R; Hiesiger E; Nelson J; Goldstein M Am J Med Sci; 1985 Sep; 290(3):102-6. PubMed ID: 4050844 [TBL] [Abstract][Full Text] [Related]
56. [Randomized study during a year of early combination of L-dopa/lisuride in Parkinson disease]. Vermersch P; Fondarai J; Petit H Therapie; 1991; 46(6):481-6. PubMed ID: 1819154 [TBL] [Abstract][Full Text] [Related]
57. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related]
58. Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study. Battistin L; Bardin PG; Ferro-Milone F; Ravenna C; Toso V; Reboldi G Acta Neurol Scand; 1999 Jan; 99(1):36-42. PubMed ID: 9925236 [TBL] [Abstract][Full Text] [Related]
60. Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group. Allain H; Destée A; Petit H; Patay M; Schück S; Bentué-Ferrer D; Le Cavorzin P Eur Neurol; 2000; 44(1):22-30. PubMed ID: 10894991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]